NCT07034768View on ClinicalTrials.gov

A Study to Evaluate EDG-7500 in People With Renal Impairment

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 22, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Renal Impairments
Interventions
DRUG

EDG-7500

Single dose of EDG-7500

Trial Locations (2)

32809

RECRUITING

Orlando Clinical Research Center, Orlando

33136

RECRUITING

The University of Miami Division of Clinical Pharmacology, Miami

Sponsors
All Listed Sponsors
lead

Edgewise Therapeutics, Inc.

INDUSTRY